Kesimpta (ofatumumab)

pCPA File Number: 21407
Negotiation Status:
Under consideration for negotiation
Indication(s):
Relapsing-Remitting Multiple Sclerosis
Sponsor/Manufacturer:
Novartis Pharma Canada Inc.
CADTH Project Number:
SR0657-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable